WO1999037678A3 - Antimicrobial peptides - Google Patents

Antimicrobial peptides Download PDF

Info

Publication number
WO1999037678A3
WO1999037678A3 PCT/NL1999/000045 NL9900045W WO9937678A3 WO 1999037678 A3 WO1999037678 A3 WO 1999037678A3 NL 9900045 W NL9900045 W NL 9900045W WO 9937678 A3 WO9937678 A3 WO 9937678A3
Authority
WO
WIPO (PCT)
Prior art keywords
amino acids
domain
antimicrobial peptides
majority
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NL1999/000045
Other languages
French (fr)
Other versions
WO1999037678A2 (en
Inventor
Nieuw Amerongen Arie Van
Engelmundus Cornelis I Veerman
T Hof Willem Van
Eva Josephine Helmerhorst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting voor de Technische Wetenschappen STW
Original Assignee
Stichting voor de Technische Wetenschappen STW
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting voor de Technische Wetenschappen STW filed Critical Stichting voor de Technische Wetenschappen STW
Priority to CA002319094A priority Critical patent/CA2319094C/en
Priority to JP2000528598A priority patent/JP2003524578A/en
Priority to EP99902926A priority patent/EP1051433B1/en
Priority to US09/601,124 priority patent/US6638531B1/en
Priority to DE69920877T priority patent/DE69920877T2/en
Priority to AT99902926T priority patent/ATE278710T1/en
Priority to AU23014/99A priority patent/AU759026B2/en
Publication of WO1999037678A2 publication Critical patent/WO1999037678A2/en
Publication of WO1999037678A3 publication Critical patent/WO1999037678A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to peptides with antimicrobial activity, consisting of an amino acid chain which contains a domain of 10 to 25 amino acids, wherein the majority of the amino acids of the one half of the domain are positively charged amino acids and the majority of the amino acids of the other half of the domain are uncharged amino acids.
PCT/NL1999/000045 1998-01-27 1999-01-26 Antimicrobial peptides Ceased WO1999037678A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA002319094A CA2319094C (en) 1998-01-27 1999-01-26 Antimicrobial peptides
JP2000528598A JP2003524578A (en) 1998-01-27 1999-01-26 Antimicrobial peptide
EP99902926A EP1051433B1 (en) 1998-01-27 1999-01-26 Antimicrobial peptides
US09/601,124 US6638531B1 (en) 1998-01-27 1999-01-26 Antimicrobial peptides
DE69920877T DE69920877T2 (en) 1998-01-27 1999-01-26 ANTIMICROBIAL EFFECTIVE PEPTIDE
AT99902926T ATE278710T1 (en) 1998-01-27 1999-01-26 ANTIMICROBIAL PEPTIDES
AU23014/99A AU759026B2 (en) 1998-01-27 1999-01-26 Antimicrobial peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1008139 1998-01-27
NL1008139A NL1008139C2 (en) 1998-01-27 1998-01-27 Antimicrobial peptides.

Publications (2)

Publication Number Publication Date
WO1999037678A2 WO1999037678A2 (en) 1999-07-29
WO1999037678A3 true WO1999037678A3 (en) 1999-10-14

Family

ID=19766423

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL1999/000045 Ceased WO1999037678A2 (en) 1998-01-27 1999-01-26 Antimicrobial peptides

Country Status (10)

Country Link
US (1) US6638531B1 (en)
EP (1) EP1051433B1 (en)
JP (1) JP2003524578A (en)
AT (1) ATE278710T1 (en)
AU (1) AU759026B2 (en)
CA (1) CA2319094C (en)
DE (1) DE69920877T2 (en)
ES (1) ES2229669T3 (en)
NL (1) NL1008139C2 (en)
WO (1) WO1999037678A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1091774B1 (en) * 1998-07-02 2002-10-30 Stichting Skeletal Tissue Engineering Group Amsterdam Bone cement with antimicrobial peptides
NL1010692C2 (en) * 1998-12-01 2000-06-06 Stichting Tech Wetenschapp Antiviral peptides.
EP1174027A1 (en) * 2000-07-17 2002-01-23 HOM Consultancy B.V. Uses of antimicrobial peptides
US7550558B2 (en) * 2001-06-01 2009-06-23 Fundacao De Ampara A Pesquiso Do Estado De Sao Paolo (Fapesp) Antimicrobial peptides and methods for identifying and using such peptides
WO2005019241A2 (en) * 2003-08-18 2005-03-03 E.I. Dupont De Nemours And Company Cationic antimicrobial peptides and compositions thereof
JP2005350424A (en) * 2004-06-14 2005-12-22 Kyocera Chemical Corp Solid preparation and method for producing the same
WO2013039861A2 (en) 2011-09-12 2013-03-21 modeRNA Therapeutics Engineered nucleic acids and methods of use thereof
WO2013151663A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of membrane proteins
CN108949772A (en) 2012-04-02 2018-12-07 现代泰克斯公司 For generating the modification polynucleotides of biological agent relevant to human diseases and protein
US8963676B1 (en) * 2013-03-12 2015-02-24 XP Power Limited Configurable transformer module
WO2014144004A1 (en) 2013-03-15 2014-09-18 The Board Of Trustees Of The University Of Arkansas Peptides with antifungal activity and methods of using the peptides
EP3423477B1 (en) 2015-06-30 2021-09-29 Chain Antimicrobials OY New antimicrobial peptides, their variants and uses
WO2017001732A1 (en) 2015-06-30 2017-01-05 Oulun Yliopisto New antimicrobial peptides, their variants and uses
JP6823789B2 (en) 2015-06-30 2021-02-03 チェイン アンチマイクロバイアルズ オイＣｈａｉｎ Ａｎｔｉｍｉｃｒｏｂｉａｌｓ Ｏｙ New antimicrobial peptides, variants and uses thereof
US11168131B2 (en) 2015-11-10 2021-11-09 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
JP6658265B2 (en) * 2016-04-26 2020-03-04 ライオン株式会社 Method for producing in vitro biofilm model, evaluation method and method for selecting oral composition
ES2994374T3 (en) 2017-01-18 2025-01-23 Visterra Inc Antibody molecule-drug conjugates and uses thereof
EP3737750B1 (en) 2018-01-09 2024-06-05 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
ES3032290T3 (en) 2018-03-20 2025-07-16 Theriva Biologics Inc Intestinal alkaline phosphatase formulations
WO2019183209A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
KR20220005560A (en) 2019-05-06 2022-01-13 신세틱 바이오로직스, 인코퍼레이티드 Alkaline Phosphate-Based Oncology Therapeutics
EP4126064A1 (en) 2020-04-03 2023-02-08 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012815A1 (en) * 1990-02-23 1991-09-05 Bristol-Myers Squibb Company COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO β-LACTAM ANTIBIOTICS
WO1992001462A1 (en) * 1990-07-19 1992-02-06 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
WO1993024138A1 (en) * 1992-06-01 1993-12-09 Magainin Pharmaceuticals, Inc. Biologically active peptides having n-terminal substitutions
WO1996008270A2 (en) * 1994-09-13 1996-03-21 Magainin Pharmaceuticals Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
WO1996040251A1 (en) * 1995-06-07 1996-12-19 Ophidian Pharmaceuticals, Inc. Prevention and treatment of sepsis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012815A1 (en) * 1990-02-23 1991-09-05 Bristol-Myers Squibb Company COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO β-LACTAM ANTIBIOTICS
WO1992001462A1 (en) * 1990-07-19 1992-02-06 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
WO1993024138A1 (en) * 1992-06-01 1993-12-09 Magainin Pharmaceuticals, Inc. Biologically active peptides having n-terminal substitutions
WO1996008270A2 (en) * 1994-09-13 1996-03-21 Magainin Pharmaceuticals Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
WO1996040251A1 (en) * 1995-06-07 1996-12-19 Ophidian Pharmaceuticals, Inc. Prevention and treatment of sepsis

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AOYAGI H ET AL: "SYNTHESIS OF ANTIBACTERIAL PEPTIDES, GRAMICIDIN S ANALOGS AND DESIGNED AMPHIPHILIC OLIGOPEPTIDES", TETRAHEDRON, vol. 44, no. 3, 1 January 1988 (1988-01-01), pages 877 - 886, XP000574054 *
CHEMICAL ABSTRACTS, vol. 103, no. 19, 11 November 1985, Columbus, Ohio, US; abstract no. 160837, SASAKI, TOORU ET AL: "Syntheses and properties of H-[Orn-Leu]n-OH (n = 1-12) and cyclo[Orn-Leu-]n (n = 2-8)" XP002083173 *
CHEMICAL ABSTRACTS, vol. 106, no. 25, 22 June 1987, Columbus, Ohio, US; abstract no. 214352, MIHARA, HISAKAZU ET AL: "Design and synthesis of basic amphiphilic peptides possessing antimicrobial activity and their interaction with lipids" XP002083172 *
MIHARA, HISAKAZU ET AL: "Design and synthesis of amphiphilic basic peptides with antibacterial activity and their interaction with model membrane", BULL. CHEM. SOC. JPN. (1987), 60(2), 697-706 CODEN: BCSJA8;ISSN: 0009-2673, 1987, XP002083171 *
PEPT. CHEM. (1985), VOLUME DATE 1984, 22ND, 361-6 CODEN: PECHDP;ISSN: 0388-3698, 1985 *
PEPT. CHEM. (1986), VOLUME DATE 1985, 23RD, 223-8 CODEN: PECHDP;ISSN: 0388-3698, 1986 *
TAKAHASHI, SHO ET AL: "Synthesis of.alpha.-helices having a positively charged random coil-block on either N- or C-terminal", BULL. CHEM. SOC. JPN. (1988), 61(7), 2467-71 CODEN: BCSJA8;ISSN: 0009-2673, 1988, XP002083167 *
TOSSI, ALESSANDRO ET AL: "Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes", FEBS LETT. (1994), 339(1-2), 108-12 CODEN: FEBLAL;ISSN: 0014-5793, 1994, XP002083170 *

Also Published As

Publication number Publication date
US6638531B1 (en) 2003-10-28
EP1051433A2 (en) 2000-11-15
JP2003524578A (en) 2003-08-19
DE69920877D1 (en) 2004-11-11
ATE278710T1 (en) 2004-10-15
AU759026B2 (en) 2003-04-03
AU2301499A (en) 1999-08-09
ES2229669T3 (en) 2005-04-16
NL1008139C2 (en) 1999-07-28
CA2319094C (en) 2009-03-17
DE69920877T2 (en) 2005-02-03
CA2319094A1 (en) 1999-07-29
EP1051433B1 (en) 2004-10-06
WO1999037678A2 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
CA2319094A1 (en) Antimicrobial peptides
WO2001079464A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
WO2001079465A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
ZA972439B (en) Amino acid fermentation processes.
WO2003012105A3 (en) Vegf isoform
ZA981569B (en) An engineered seed protein having a higher percentage of essential amino acids.
ZA987126B (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives.
WO1995018855A3 (en) Synthetic antimicrobial peptides
AU4697396A (en) Peptide, peptide analog and amino acid analog protease inibitors
WO1997030082A3 (en) Antifungic and antibacterial peptide
WO2000067801A3 (en) Prodrugs of chemotherapeutic agents with oxaalkanoic acids
AU1692399A (en) Aromatic compounds having cyclic amino or salts thereof
AU9485598A (en) Peptide nucleic acids having antibacterial activity
CY2341B1 (en) Bicyclic amino acids.
KR0180256B1 (en) Bpc peptides, their preparation and use
EP1262556A3 (en) Antimicrobial peptides and method for identifying and using such peptides
EP1681350A3 (en) Porphorymonas gingivalis polypeptides and polynucleotides
WO1999037782A3 (en) Frozen food product
EP1006126A3 (en) Osteogenic peptides
WO2000043490A3 (en) Rhamnosyl-transferase gene and uses thereof
CA2340934A1 (en) Novel collectin
WO2000032629A3 (en) Antiviral peptides
AU5985098A (en) 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect
CA2235771A1 (en) Rhodosporidium d-amino acid oxidase
ZA971022B (en) N-(3,3-dimethylbutyl)-l-aspartyl-d-alpha-aminoalkanyoic acid n-(s)- 1-phenyl-1-alkanamide useful as a sweeting agent.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2319094

Country of ref document: CA

Ref country code: CA

Ref document number: 2319094

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 23014/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999902926

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09601124

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999902926

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 23014/99

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1999902926

Country of ref document: EP